![](/img/cover-not-exists.png)
Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: A cost-effectiveness analysis
Robert E. Bristow, Antonio Santillan, Ritu Salani, Teresa P. Diaz-Montes, Robert L. Giuntoli II, Benjamin C. Meisner, Deborah K. Armstrong, Kevin D. FrickVolume:
106
Year:
2007
Language:
english
Pages:
6
DOI:
10.1016/j.ygyno.2007.05.043
File:
PDF, 369 KB
english, 2007